The Alabama Medical Cannabis Commission Awards Three Dispensary License

December 11, 2025 - MONTGOMERY, Ala. - The Alabama Medical Cannabis Commission issued three of the four statutorily required dispensary licenses to in-state businesses earlier today.

The Darren Wesley "Ato" Hall Compassion Act tasked the Alabama Medical Cannabis Commission with issuing dispensary licenses to qualified operators across the state.

These licenses authorize approved companies to sell regulated medical cannabis products, including oils, capsules, topicals, and other permitted forms, to registered patients. Dispensary license holders must meet strict standards for security, product tracking, and regulatory compliance.

The awarded licensees are GP6 Wellness, RJK Holdings, and CCS of Alabama. However, it should be noted that the fourth statutorily required license has not been awarded pending an appeal by another applicant, Capitol Medical.

Capitol Medical is appealing the awarding of the fourth and final license to Yellowhammer Medical. The Alabama Administrative Procedure Act allows any party denied in an administrative proceeding to receive a set period for appeal.

Consequently, the Commission granted Capitol Medical 46 days to file its appeal in accordance with state law.

All awardees are required to pay the license fee within 14 days. After payment is received and an additional 14 days have passed, the licenses will be officially awarded.

The AMCA is a distinct entity from the Alabama Medical Cannabis Commission. AMCA works to promote a safe, well-regulated, and patient-centered medical cannabis program by providing education, advocacy, and resources to its members.